Live news related to ABIVAX stock (FR0012333284): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
French biotech company Abivax has announced the completion of its public offering of American Depositary Shares (ADS) in the United States, raising a …
The French biotech resumes trading in Paris with a strong increase, following the completion of its ADS offering in the United States. The stock takes…
French biotech company Abivax announces a temporary suspension of the trading of its ordinary shares on Euronext Paris starting from the opening, as p…
French biotech company Abivax has announced the launch of a public offering of American Depositary Shares (ADS) amounting to approximately $600 millio…
The French biotech company had a spectacular mid-day trading session, catapulting to the top of the broad Paris index. The stock erased several weeks …
Abivax has announced positive results from Part 2 of the ABTECT maintenance trial, showing that its candidate obefazimod restores clinical remission i…
The French biotech company experiences another session in the red, extending a downward trend that has been in place for several weeks. The stock is m…
The French biotech faces another tough session at close, erasing the rebound sketched the previous day. The stock is among the biggest losers in the b…
The French biotech firm shows signs of recovery at the opening, after several weeks of significant decline. The stock climbs to the top of the broad P…
The French biotech company falls during the session and sinks to the bottom of the broad Parisian index. The stock extends a decline that began severa…
